awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27005850-B89DABC3-555B-4309-856A-579673A25650
Q27005850-B89DABC3-555B-4309-856A-579673A25650
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005850-B89DABC3-555B-4309-856A-579673A25650
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
P2860
Q27005850-B89DABC3-555B-4309-856A-579673A25650
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27005850-B89DABC3-555B-4309-856A-579673A25650
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe88f882cb00ea6c1c8b1ee91f3d5940e9e94772
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.